Results 181 to 190 of about 9,354,751 (270)

Biosimilar Rituximab in ANCA-Associated Vasculitis Compared to the Originator: A Multicenter Cohort Study. [PDF]

open access: yesACR Open Rheumatol
Mendel A   +14 more
europepmc   +1 more source

Clinical scenarios of suboptimal response to rituximab in relapsing ANCA-associated vasculitis. [PDF]

open access: yesFront Med (Lausanne)
Prieto-González S   +6 more
europepmc   +1 more source

Pathogenesis and therapeutic interventions for ANCA-associated vasculitis

open access: yesNature Reviews Rheumatology, 2018
Daigo Nakazawa   +3 more
semanticscholar   +1 more source

Hypogammaglobulinaemia in patients with ANCA-associated vasculitis treated with rituximab. [PDF]

open access: yesFront Med (Lausanne)
Rathmann J   +4 more
europepmc   +1 more source

Association of FHR5 With Disease Severity in ANCA-Associated Vasculitis. [PDF]

open access: yesKidney Int Rep
Li YJ   +7 more
europepmc   +1 more source

Rituximab With or Without Avacopan in ANCA-Associated Vasculitis With Severe Renal Involvement. [PDF]

open access: yesKidney Int Rep
Juanet C   +13 more
europepmc   +1 more source

Therapeutic plasma exchange in paediatric ANCA-associated vasculitis: a multicentre real-world experience. [PDF]

open access: yesRheumatology (Oxford)
Menentoğlu B   +19 more
europepmc   +1 more source

Home - About - Disclaimer - Privacy